also joined late, but think I heard him say Fosun are promoting heavily to HK-based investors Tele-health sector in US has gone from hot, to red-hot, to white-hot Final prospectus will be released post-IPO with actual # of shares and total amount raised GRS (Guthy Renker) will handle infomercial, radio, social media campaigns, possibly with celebrity endorser Sees GMED as a hybrid of BEAT/IRTC (devices) and TDOC/AMWL (telehealth) Believes appropriate revenue-multiplier (based on above 4 coys) is 30x - 50x, hence with $11M revenue should be $330-$550M MC Believes they are pricing GMED at 10-15% discount based on above revenue-multiples of comparable 4 organisations above
GMV Price at posting:
3.9¢ Sentiment: Buy Disclosure: Held
